Female Infertility
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Bharat Serums & VaccinesIndia - Mumbai
1 program1
Recombinant Human Follicle Stimulating Hormone 900 IUPhase 31 trial
Active Trials
Ferring PharmaceuticalsArgentina - Buenos Aires
1 programStudy of the Cleavage of the Egg in Relation to the Stimulation TreatmentN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Bharat Serums & VaccinesRecombinant Human Follicle Stimulating Hormone 900 IU
Ferring PharmaceuticalsStudy of the Cleavage of the Egg in Relation to the Stimulation Treatment
Clinical Trials (2)
Total enrollment: 356 patients across 2 trials
Recombinant Follicle-stimulating Hormone in Treatment for Infertility
Start: Jul 2022Est. completion: Nov 2023
Phase 3Unknown
NCT01674894Ferring PharmaceuticalsStudy of the Cleavage of the Egg in Relation to the Stimulation Treatment
Study of the Cleavage of the Egg in Relation to the Stimulation Treatment
Start: Jan 2013Est. completion: Mar 2016356 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space